Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Replimune Inc.
Dana-Farber Cancer Institute
BicycleTx Limited
Nanobiotix
University of Kansas Medical Center
Dana-Farber Cancer Institute
Bristol-Myers Squibb
Instituto do Cancer do Estado de São Paulo
Washington University School of Medicine
Providence Health & Services